Vivos Total Assets from 2010 to 2024

VVOS Stock

USD 3.40 0.12 3.41%

Vivos Therapeutics Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

10.7 M

Current Value

18.2 M

Quarterly Volatility

7.7 M

Credit Downgrade

Yuan Drop

Covid

Check Vivos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivos Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 0.0 or Interest Income of 141.3 K, as well as many indicators such as Price To Sales Ratio of 1.04, Dividend Yield of 0.0 or PTB Ratio of 38.75. Vivos financial statements analysis is a perfect complement when working with Vivos Therapeutics Valuation or Volatility modules.

Check out the analysis of Vivos Therapeutics Correlation against competitors.

For more information on how to buy Vivos Stock please use our How to Invest in Vivos Therapeutics guide.

Latest Vivos Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Vivos Therapeutics over the last few years. Total assets refers to the total amount of Vivos Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Vivos Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Vivos Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivos Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 10.73 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Vivos Total Assets Regression Statistics

	Arithmetic Mean	12,202,960
	Geometric Mean	10,736,817
	Coefficient Of Variation	63.47
	Mean Deviation	5,615,376
	Median	8,203,967
	Standard Deviation	7,744,998
	Sample Variance	60T
	Range	26.1M
	R-Value	0.55
	Mean Square Error	45.4T
	R-Squared	0.30
	Significance	0.04
	Slope	945,176
	Total Sum of Squares	839.8T

Vivos Total Assets History

	2024	18.2 M
	2023	10.7 M
	2022	13.7 M
	2021	33.7 M
	2020	25.3 M
	2019	7.6 M

Other Fundumenentals of Vivos Therapeutics

Intangibles To Total Assets

Vivos Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.83	0.68	0.61	-0.92	-0.48	0.27	-0.59	0.72	-0.6	0.51	0.83	0.23	0.94	0.33	0.83	0.2	-0.75	0.66	0.38
Total Stockholder Equity	0.83		0.3	0.17	-0.97	-0.02	-0.16	-0.09	0.84	-0.09	0.04	0.99	-0.19	0.93	0.63	1.0	-0.05	-0.34	0.31	0.18
Net Tangible Assets	0.68	0.3		0.66	-0.41	-0.95	0.77	-0.82	0.02	-0.78	0.7	0.24	0.28	0.47	-0.2	0.27	-0.01	-0.85	0.95	0.77
Current Deferred Revenue	0.61	0.17	0.66		-0.37	-0.73	0.71	-0.92	0.34	-0.95	0.95	0.21	0.81	0.5	0.09	0.17	0.67	-0.94	0.74	0.43
Net Debt	-0.92	-0.97	-0.41	-0.37		0.17	0.0	0.3	-0.87	0.3	-0.25	-0.97	0.0	-0.99	-0.54	-0.97	-0.09	0.52	-0.45	-0.22
Retained Earnings	-0.48	-0.02	-0.95	-0.73	0.17		-0.91	0.9	0.15	0.85	-0.81	0.02	-0.49	-0.25	0.34	0.01	-0.16	0.85	-0.93	-0.8
Accounts Payable	0.27	-0.16	0.77	0.71	0.0	-0.91		-0.88	-0.19	-0.83	0.86	-0.18	0.63	0.11	-0.4	-0.19	0.34	-0.77	0.87	0.79
Long Term Debt	-0.59	-0.09	-0.82	-0.92	0.3	0.9	-0.88		-0.13	0.99	-0.97	-0.1	-0.75	-0.41	0.24	-0.08	-0.5	0.94	-0.88	-0.61
Net Receivables	0.72	0.84	0.02	0.34	-0.87	0.15	-0.19	-0.13		-0.18	0.19	0.9	0.17	0.88	0.7	0.86	0.42	-0.33	0.13	-0.08
Good Will	-0.6	-0.09	-0.78	-0.95	0.3	0.85	-0.83	0.99	-0.18		-0.98	-0.11	-0.79	-0.42	0.2	-0.09	-0.56	0.94	-0.83	-0.51
Total Liab	0.51	0.04	0.7	0.95	-0.25	-0.81	0.86	-0.97	0.19	-0.98		0.07	0.86	0.38	-0.14	0.03	0.67	-0.92	0.8	0.56
Net Invested Capital	0.83	0.99	0.24	0.21	-0.97	0.02	-0.18	-0.1	0.9	-0.11	0.07		-0.11	0.95	0.66	0.99	0.06	-0.34	0.27	0.13
Short Long Term Debt	0.23	-0.19	0.28	0.81	0.0	-0.49	0.63	-0.75	0.17	-0.79	0.86	-0.11		0.15	-0.12	-0.18	0.92	-0.63	0.41	0.27
Total Current Assets	0.94	0.93	0.47	0.5	-0.99	-0.25	0.11	-0.41	0.88	-0.42	0.38	0.95	0.15		0.55	0.93	0.24	-0.62	0.52	0.28
Capital Stock	0.33	0.63	-0.2	0.09	-0.54	0.34	-0.4	0.24	0.7	0.2	-0.14	0.66	-0.12	0.55		0.62	0.19	-0.05	-0.12	-0.11
Net Working Capital	0.83	1.0	0.27	0.17	-0.97	0.01	-0.19	-0.08	0.86	-0.09	0.03	0.99	-0.18	0.93	0.62		-0.03	-0.33	0.28	0.13
Short Term Debt	0.2	-0.05	-0.01	0.67	-0.09	-0.16	0.34	-0.5	0.42	-0.56	0.67	0.06	0.92	0.24	0.19	-0.03		-0.44	0.15	0.06
Intangible Assets	-0.75	-0.34	-0.85	-0.94	0.52	0.85	-0.77	0.94	-0.33	0.94	-0.92	-0.34	-0.63	-0.62	-0.05	-0.33	-0.44		-0.91	-0.61
Common Stock	0.66	0.31	0.95	0.74	-0.45	-0.93	0.87	-0.88	0.13	-0.83	0.8	0.27	0.41	0.52	-0.12	0.28	0.15	-0.91		0.82
Property Plant Equipment	0.38	0.18	0.77	0.43	-0.22	-0.8	0.79	-0.61	-0.08	-0.51	0.56	0.13	0.27	0.28	-0.11	0.13	0.06	-0.61	0.82

Click cells to compare fundamentals

About Vivos Therapeutics Financial Statements

Vivos Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Vivos Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Vivos Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Vivos Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	10.7 M	18.2 M
Intangibles To Total Assets	0.30	0.33

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vivos Stock Analysis

When running Vivos Therapeutics' price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC